Table 1.
Patient and baseline characteristics (N = 12)
| Characterisitcs | Values |
|---|---|
| Sex (female), % | 38 |
| Age (years) | 60 (49–82) |
| Dialysis vintage (months) | 96 (16–233) |
| P-hsCRP (mg/mL) | 6 (0.4–44.6) |
| B-Hb (g/L) | 106 (97–113) |
| B-WBCs (×109) | 6.4 (4.8–10.2) |
| B-monocytes (×109) | 00.7 (0.4–1.0) |
| B-lymphocytes (×109) | 1.4 (0.8–1.9) |
| S-TNF (pg/mL) | 20.3 (14.2–77.4)a |
| S-IL-1b (pg/mL) | 1.3 (0.3–9.2)a |
| S-IL-10 (pg/mL) | 1.2 (0.8–2.6)a |
| Medications, n | |
| β-blocker | 6 |
| α-blocker | 1 |
| Calcium channel antagonist | 5 |
| ACE/ARB inhibitor | 6 |
| Furosemide | 4 |
| Statin | 3 |
Values presented as median (10th–89th percentiles).
References: hsCRP <3 mg/L; B-Hb 117–153 g/L (female), 134–170 g/L (male); B-WBCs 3.5–8.8 × 109/L; B-monocytes 0.1–1.0 × 109/L; B-lymphocytes 1.0–1.4 × 109; S-TNF <12 pg/mL; S-IL-1b <5 pg/mL; S-IL-10 <5 pg/mL.
aBaseline values before stimulation in the LPS model.
undefined
P: plasma; hsCRP: high-sensitivity CRP; B: blood; S: serum.